SILVERMAN JOSHUA purchased 31.6% of their position (100K shares) of PHARMACYTE BIOTECH, INC. on the open market
Open‑market purchase worth $80.5K — a major conviction buy. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 1/7/2026ACC: 0001683168-26-000148
+100K
Net shares
Net buyer
$80.5K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
100K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+30K
Price / share
$0.78
Trade value
$23.49K
% of position
9.5%
1/5/2026
316.25K→346.25K
Common Stock
Direct
Shares
+30K
Price / share
$0.79
Trade value
$23.67K
% of position
8.7%
1/6/2026
346.25K→376.25K
Common Stock
Direct
Shares
+40K
Price / share
$0.83
Trade value
$33.32K
% of position
10.6%
1/7/2026
376.25K→416.25K
Total
Net shares
+100K
Net value
$80.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/5/2026 | P · Purchase | +30K | $0.78 | $23.49K | 9.5% | 316.25K | 346.25K |
| Common Stock Direct | 1/6/2026 | P · Purchase | +30K | $0.79 | $23.67K | 8.7% | 346.25K | 376.25K |
| Common Stock Direct | 1/7/2026 | P · Purchase | +40K | $0.83 | $33.32K | 10.6% | 376.25K | 416.25K |
| Total | +100K | $80.48K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned50K
Total
50K indirect50K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 50K | Indirect |
| Total | 50K | 50K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported